Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer
Not yet recruitingOBSERVATIONAL
Enrollment
55
Participants
Timeline
Start Date
July 31, 2025
Primary Completion Date
June 30, 2027
Study Completion Date
June 30, 2027
Conditions
Ototoxic Hearing LossOtotoxicity, Drug-InducedCisplatin-induced Hearing LossCisplatin OtotoxicityHead and Neck CancerDizzynessInner Ear Hearing LossVestibular DiseaseSquamous Cell Carcinoma of the Head and NeckDeafnessHearing Loss
Trial Locations (1)
90419
Klinikum Nuremberg, Nuremberg
All Listed Sponsors
collaborator
Klinikum Nürnberg
OTHER
lead
Simon Jäger
OTHER
NCT06929468 - Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer | Biotech Hunter | Biotech Hunter